Drug provision and health technology assessment in France
The article presents the description of structural, organizational and methodological issues of health technology assessment (HTA) of French drugs as well as the state-reimbursable list of drugs. The HTA is conducted by an independent public body – French National Authority for Health (HAS). HAS eva...
Saved in:
Main Authors: | V. V. Omelyanovskiy, A. V. Nikitina, V. A. Lemeshko, G. R. Khachatryan |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IRBIS LLC
2020-04-01
|
Series: | Фармакоэкономика |
Subjects: | |
Online Access: | https://www.pharmacoeconomics.ru/jour/article/view/344 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The health technology assessment system in Australia
by: V. V. Omelyanovskiy, et al.
Published: (2020-02-01) -
Health technology assessment and reimbursement of pharmaceuticals in Italy
by: F. V. Gorkavenko, et al.
Published: (2019-07-01) -
IS RUSSIA READY FOR THE INTRODUCTION OF THE NATIONAL REFERENCE PRICING SYSTEM?
by: V. V. Omelyanovskiy
Published: (2015-05-01) -
Development of a method for the analysis of the lists of medicines and its application for the analysis of the lists of medicines in Russia, England, and Italy
by: V. A. Lemeshko, et al.
Published: (2021-04-01) -
Introduction of medical products into healthcare practice and costs reimbursement: European experience
by: V. V. Omelyanovsky, et al.
Published: (2018-08-01)